COMBINATION OF LACHINIMODE AND PRIDOPIDINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

摘要

The invention provides a method for treating a patient suffering from a neurodegenerative disorder, such as Huntington's disease (HD), which includes administering Lachinimod to the patient as an adjunctive therapy or in combination with priopidine. The invention also proposed packaging and pharmaceutical composition, including lachinimide and priopidin, for the treatment of a patient suffering from a neurodegenerative disorder, such as HD. The invention also provides lachinimode for use as an adjunctive therapy or in combination with dopedine for treating a patient suffering from a neurodegenerative disorder, such as HD. The invention also provides for the use of lachinimide and dopopidine in the preparation of a combination for treating a patient suffering from a neurodegenerative disorder, for example HD.